BPC-157
BPC-157 Price range: $24.00 through $40.00
Back to products
AOD9604
AOD9604 Original price was: $55.00.Current price is: $44.00.

Ara-290 (10mg)

15 BOUGHT IN LAST 24H

Original price was: $49.50.Current price is: $39.60.

62 in stock

Veteran Support
Mission Driven
Same-Day
Shipping
Third-Party
Tested
Secure
Checkout
SCIENTIFIC SPECIFICATIONS
Molecular Formula
C512H84N16O21
CAS
1208243-50-8
Molar Mass
1257.3 g/mol
Chemical Formula
C78H123N23O21S
Amino Acid Sequence
Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
Synonyms
Pyroglutamate Helix B Surface Peptide, pHBSP, ARA 290, Cibinetide
Solubility
Water-soluble
Organoleptic Profile
White to off-white powder
Composition
Lyophilized powder – requires reconstitution
Research Use Only
● VERIFIED ANALYSIS

Third-Party Lab Results

Transparency is our priority. Download the full HPLC and Mass Spectrometry reports for the current batch #88291. Tested on Oct 24, 2023.

DOWNLOAD FULL REPORT (PDF)
PDF
HPLC_BPC157_Batch88291.pdf
Verified by Janoshik
PDF
MS_BPC157_Batch88291.pdf
Verified by Janoshik
Research Overview

ARA-290 is a small peptide derived from the structure of erythropoietin (EPO) and designed to selectively engage tissue-protective signaling pathways without the hematopoietic effects typically associated with EPO. In research settings, ARA-290 is primarily investigated for its interaction with the so-called innate repair receptor (IRR) and tissue-protective receptor (TPR), where it has been shown in preclinical and early clinical studies to influence inflammatory signaling, vascular repair mechanisms, neuropathic pain pathways, and wound-healing processes.

Supplied strictly as a research compound, ARA-290 is intended for use in controlled laboratory experiments only. It is not approved for human or veterinary consumption, diagnosis, treatment, or prevention of any disease.

ARA-290 is a non-erythropoietic EPO analogue engineered to retain tissue-protective and anti-inflammatory properties while minimizing effects on red blood cell production and cardiovascular parameters. By targeting specific EPO-related receptor complexes (often referred to as IRR/TPR), ARA-290 is used to explore:

  • Modulation of inflammatory cytokine release
  • Protection and repair of vascular and endothelial cells
  • Regulation of immune-cell activity and antigen presentation
  • Neural repair mechanisms and small fiber nerve integrity
  • Wound repair and tissue regeneration in ischemic or inflammatory environments

Preclinical and translational research has examined ARA-290 in models of vascular injury, islet transplantation, autoimmune conditions, neuropathic pain, and small fiber neuropathy, making it a versatile tool for studying tissue protection and immune modulation.

 

Storage & Handling

All peptides are supplied as sterile, lyophilized powder and are stable when handled correctly.

  • On arrival: Store vials in a cool, dry place away from heat and direct sunlight.
  • Long-term (powder): For optimal longevity, keep lyophilized peptides refrigerated to help maintain integrity.
  • After reconstitution: Use an appropriate research diluent (for example, BAC water). Store the reconstituted solution in the refrigerator and use within 20–30 days for best stability.

Note: Minimize exposure to moisture and repeated freeze–thaw cycles. Follow your institution's safety procedures when handling research materials.

FAQ 

Q1: What is ARA-290 in a research context?
A1: ARA-290 is a non-erythropoietic peptide derived from erythropoietin, used in research to study tissue protection, immune modulation, vascular repair, and neuropathic pain mechanisms via the innate repair/tissue-protective receptor pathways.

Q2: What are the main experimental applications of ARA-290?
A2:
Common research applications include models of vascular and endothelial repair, islet transplantation, autoimmune and inflammatory diseases, neuropathic pain, small fiber neuropathy, and wound healing in metabolic disease.

Q3: How does ARA-290 differ from full-length erythropoietin (EPO)?
A3: ARA-290 is designed to selectively activate tissue-protective receptor complexes without stimulating the hematopoietic and many cardiovascular effects associated with full-length EPO, making it more suitable for focused tissue-protection and immune-modulation research.

Q4: Is ARA-290 intended for human or veterinary use?
A4: No. ARA-290 from research suppliers is for laboratory use only and is not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any condition.

Q5: Why is ARA-290 of interest in neuropathy research?
A5:
ARA-290 has been studied for its effects on small nerve fiber integrity, inflammatory signaling, and TRPV1-related pain pathways, making it a valuable compound for investigating mechanisms underlying neuropathic pain and small fiber neuropathy in controlled studies.

 

i
Research Use Only: This product is intended for laboratory research use only and is not for human consumption, diagnostic, or therapeutic use.

Researcher Reviews

Reviews

There are no reviews yet.

Be the first to review “Ara-290 (10mg)”

Your email address will not be published. Required fields are marked *